Companies / Ocular Therapeutix, Inc

Ocular Therapeutix, Inc

Nasdaq: OCULCIK 1393434BEDFORD, MA

Financials · FY2025

Revenue$51.95M
Net income$-265.94M
Total debt$18.00M
Cash$598.64M
Diluted EPS$-1.42
Shares outstanding219.6M

Ownership

219.6M shares outstanding · as of Jul 31, 2026
2.9%Insiders
Ownership
Insiders2.88%6,315,211
10%+ / strategic4.20%9,234,132
Institutions78.73%172,894,163
Public float14.19%31,172,362

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 17

View all →
Insider% of sharesShares
Dugel PravinSee Remarks · Director
1.50%3,291,981
Notman DonaldChief Operating Officer
0.17%366,356
Nayak SanjayChief Strategy Officer
0.15%328,795
Heier Jeffrey S.Chief Scientific Officer
0.15%320,350
Waheed NadiaChief Medical Officer
0.14%300,079
Kaiser PeterChief Development Officer
0.12%266,141
Lindstrom Richard L MdDirector
0.12%260,933
Saroj NamrataChief Business Officer
0.12%254,620
Meyers Steve LawrenceChief Commercial Officer
0.10%217,628
Anderman ToddChief Legal Officer
0.07%152,468

Institutional holders 255

View all →
HolderValue% of shares
Fmr LLC$385.88M14.47%
BlackRock, Inc.$190.28M8.82%
Vanguard Group Inc$140.52M5.27%
Avoro Capital Advisors LLC$130.84M4.91%
Deep Track Capital, LP$97.97M3.67%
VR Adviser, LLC$88.81M3.33%
TCG Crossover Management, LLC$69.69M2.61%
Adage Capital Partners Gp, L.L.C.$56.15M2.11%
State Street Corporation$51.39M2.38%
AllianceBernstein L.P.$50.13M1.88%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 12, 2026Dugel Pravin
Executive
SellCommon Stock$1.13M-125K
-3.95%
3,033,078
1.38% of shares
medium
Feb 20, 2026Lindstrom Richard L Md
Director
BuyCommon Stock$461.4K+60K
+32.26%
246,933
0.11% of shares
medium
May 26, 2026Dugel Pravin
Executive
SellCommon Stock$173.5K-21K
-0.81%
2,597,170
1.18% of shares
medium
Feb 23, 2026Dugel Pravin
Executive
SellCommon Stock$166.1K-20K
-0.66%
3,013,022
1.37% of shares
medium
Jun 3, 2026Waheed Nadia
Executive
SellCommon Stock$122.6K-15K
-4.71%
300,079
0.14% of shares
medium
Feb 12, 2026Notman Donald
Executive
SellCommon Stock$103.5K-11K
-3.03%
366,356
0.17% of shares
medium
Feb 12, 2026Nayak Sanjay
Executive
SellCommon Stock$93.5K-10K
-3.02%
332,412
0.15% of shares
low
Feb 12, 2026Waheed Nadia
Executive
SellCommon Stock$71.1K-8K
-2.41%
318,417
0.14% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Deep Track Capital, LPPassive13G/A—9,234,132—
Venrock Healthcare Capital Partners III, L.P.Passive13G/A———
Deep Track Capital, LPPassive13G—11,234,132—
Deep Track Capital, LPPassive13G/A—20,850,000—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
OCUL——67576A100—